Prescription drug · ANDA
Sucralfate NDC 0093-2210
Sucralfate 1 g/1 · Tablet · Oral · Teva Pharmaceuticals USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0093-2210-01 | 00093221001 | 100 TABLET in 1 BOTTLE (0093-2210-01)Marketed from Nov 11, 1996 | |
| 0093-2210-05 | 00093221005 | 500 TABLET in 1 BOTTLE (0093-2210-05)Marketed from Nov 11, 1996 | |
| 0093-2210-98 | 00093221098 | 90 TABLET in 1 BOTTLE (0093-2210-98)Marketed from Jan 12, 2011 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sucralfate
- Generic name (nonproprietary)
- sucralfate
- Active ingredients
- Sucralfate — 1 g/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 070848
- Marketing start
- Listing expires
- Other FDA classes
- Organometallic Compounds (Chemical structure)
- Identifiers
- Product ID 0093-2210_c363786b-0fde-45c0-9575-2a4ca71aa592SPL ID c363786b-0fde-45c0-9575-2a4ca71aa592SPL set ID c7a43df7-eb37-4273-9250-87953b1fd270RxCUI 314234UNII XX73205DH5UPC 0300932210981
- Pharmacologic class
- Aluminum Complex
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400093221001followed by a unit qualifier and the quantityPackage 00093-2210-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sucralfate tablets, USP are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 070848
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Northwind Health Company, LLC | 51655-031 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Cardinal Health 107, LLC | 55154-4379 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 63629-1307 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Cardinal Health 107, LLC | 55154-0281 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | DIRECT RX | 72189-234 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8946 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-4517 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | ASCLEMED USA INC. | 87063-176 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0091 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Proficient Rx LP | 82804-063 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Safecor Health LLC | 48433-091 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Mylan Institutional Inc. | 51079-753 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-1749 |